A Prospective Randomized, Double-Blind, Multi-Center, Phase III Clinical Trial Evaluating the Efficacy and Safety of Olmesartan/Amlodipine plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia: A LEISURE Study
Sang‐Ho Jo(Hallym University Sacred Heart Hospital), Cheol Ho Kim(Seoul National University Bundang Hospital), Jae Hyoung Park(Korea University), Young Soo Lee(Government of the Republic of Korea), Byung‐Su Yoo(University of San Diego), Gee-Hee Kim(The Catholic University of Korea St. Vincent's Hospital), Seok‐Min Kang(Harvard University), Jae Myung Yu(Hallym University Kangnam Sacred Heart Hospital), Kyung Wan Min(Eulji University), Seok Yeon Kim(Seoul Medical Center), Hyun Ju Yoon(Chonnam National University Hospital), Woo Shik Kim(Kyung Hee University Medical Center), Ho‐Joong Youn
Cited by 8
Related Papers
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
|New England Journal of Medicine|2024|693
Circadian rhythm of hyperoxidized peroxiredoxin II is determined by hemoglobin autoxidation and the 20S proteasome in red blood cells
|Proceedings of the National Academy of Sciences|2014|132
Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction
|Journal of the American Heart Association|2019|113